Related references
Note: Only part of the references are listed.The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
Mateusz Legut et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor
Christian Krug et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies
Drew C. Deniger et al.
CLINICAL CANCER RESEARCH (2014)
Human cell-based artificial antigen-presenting cells for cancer immunotherapy
Marcus O. Butler et al.
IMMUNOLOGICAL REVIEWS (2014)
Design and development of therapies using chimeric antigen receptor-expressing T cells
Gianpietro Dotti et al.
IMMUNOLOGICAL REVIEWS (2014)
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Ikuo Wada et al.
CANCER MEDICINE (2014)
Clinical applications of gamma delta T cells with multivalent immunity
Drew C. Deniger et al.
FRONTIERS IN IMMUNOLOGY (2014)
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
Jean-Jacques Fournie et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Arming Cytokine-induced Killer Cells With Chimeric Antigen Receptors: CD28 Outperforms Combined CD28 OX40 Super-stimulation
Andreas A. Hombach et al.
MOLECULAR THERAPY (2013)
Sunitinib Indirectly Enhanced Anti-Tumor Cytotoxicity of Cytokine-Induced Killer Cells and CD3+ CD56+ Subset through the Co-Culturing Dendritic Cells
Adisak Wongkajornsilp et al.
PLOS ONE (2013)
Six-of-the-best: unique contributions of γδ T cells to immunology
Pierre Vantourout et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors
Giulia Mesiano et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study
Jinying Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma
Qiong J. Wang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes
B. J. R. Sluijter et al.
CLINICAL IMMUNOLOGY (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors
Virna Marin et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: Differing impact on CD8 T cell phenotype and responsiveness to restimulation
Yixin Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
Giuseppina Bonanno et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial
Paola Olioso et al.
HEMATOLOGICAL ONCOLOGY (2009)
Redirecting specificity of T-cell Populations for CD19 using the Sleeping beauty system
Harjeet Singh et al.
CANCER RESEARCH (2008)
Isopentenyl pyrophosphate-activated CD516+ γδ T lymphocytes display potent antitumor activity toward human squamous cell carcinoma
Alan A. Z. Alexander et al.
CLINICAL CANCER RESEARCH (2008)
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy
Hua Zhang et al.
JOURNAL OF IMMUNOLOGY (2007)
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
Megan M. Suhoski et al.
MOLECULAR THERAPY (2007)
Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro
Jane Kelly-Rogers et al.
HUMAN IMMUNOLOGY (2006)
Activation of V gamma 9V delta 2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication
C Agrati et al.
INTERNATIONAL IMMUNOLOGY (2006)
Human γδ T cells as mediators of chimaeric-receptor redirected anti-tumour immunity
M Rischer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts
YC Linn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells
RD Lopez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Share Paper
